价格

DM1 (CUG)

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

METHODS OF TREATING MYOTONIC DYSTROPHY TYPE 1 USING PEPTIDE-OLIGONUCLEOTIDE CONJUGATES
EP 4304657 A4申请人: PEPGEN INC优先权: 2021
CN
EP
US
WO
4 件公开
RNA-TARGETING COMPOSITIONS AND METHODS FOR TREATING MYOTONIC DYSTROPHY TYPE 1
EP 4255471 A1申请人: LOCANABIO INC优先权: 2020
EP
US
WO
3 件公开
COMPOUNDS FOR TREATING, DELAYING AND/OR PREVENTING A HUMAN GENETIC DISORDER SUCH AS MYOTONIC DYSTROPHY TYPE I (DMI)
US 2014045763 A1申请人: PROSENSA TECHNOLOGIES BV优先权: 2011
CN
US
3 件公开
Toxic RNA inhibitors self-assembled in situ
US 10220031 B2申请人: DISNEY MATTHEW D优先权: 2014
CN
US
3 件公开
COMPOSITIONS AND METHODS RELATED TO PROTEIN DISPLACEMENT THERAPY FOR MYOTONIC DISTROPHY
US 2010190689 A1申请人: UNIV ROCHESTER优先权: 2007
US
3 件公开
COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF TOXIC TRANSCRIPTS
US 2013143825 A1申请人: ARTERO ALLEPUZ RUBEN DARIO优先权: 2010
CN
US
2 件公开
Peptide-linked morpholino antisense oligonucleotides for treatment of myotonic dystrophy
CN 104837997 A申请人: GENZYME CORP优先权: 2013
CN
US
2 件公开
ANTISENSE COMPOUNDS AND METHODS FOR TARGETING CUG REPEATS
- EP 4359006 A1
  申请人: ENTRADA THERAPEUTICS INC优先权: 2021
  EP
  WO
  2 件公开
- US 20250011774 A1
  申请人: ENTRADA THERAPEUTICS INC优先权: 2023
  US
TRICYCLO-DNA ANTISENSE OLIGONUCLEOTIDES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE
US 2012149756 A1申请人: SCHUEMPERLI DANIEL优先权: 2010
US
2 件公开
Specific targeting of RNA expanded repeat sequences
US 9586944 B2申请人: SCRIPPS RESEARCH INST优先权: 2014
US
2 件公开

药物

DM1 (CUG)

专利

ANTISENSE COMPOUNDS AND METHODS FOR TARGETING CUG REPEATS